
CAR T-cells, Interview with Dr Caroline Bateman
Mar 14, 2022 - 45:55
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis. Hosted on Acast...
The MEK inhibitors: trametinib and selumetinib is an episode from Understanding Childhood Cancer With Dr Geoff by Dr Geoff. The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important...
This episode belongs to Understanding Childhood Cancer With Dr Geoff.
Use the player on this page to stream the episode online.
Published Feb 19, 2021, 41:14 long, audio available.
The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis. Hosted on Acast. See acast.com/privacy for more information.
You can listen to The MEK inhibitors: trametinib and selumetinib online on Radio and Podcast. Open the player on this page to stream the available audio.
The MEK inhibitors: trametinib and selumetinib is an episode from Understanding Childhood Cancer With Dr Geoff by Dr Geoff.
This episode is 41:14 long.
This episode was published on Feb 19, 2021.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Understanding Childhood Cancer With Dr Geoff when more episodes are available from the podcast feed.
You can listen to The MEK inhibitors: trametinib and selumetinib on this page when the episode audio is available from the podcast feed.
The MEK inhibitors: trametinib and selumetinib is from Understanding Childhood Cancer With Dr Geoff by Dr Geoff.
Published Feb 19, 2021 and 41:14 long